| 1 |
Salvatore J. Salamone |
Saladax Biomedical |
43 |
| 2 |
Thomas Nosker |
Rutgers, The State University Of New Jersey |
41 |
| 3 |
David Grover |
As America |
38 |
| #4 |
Robert L. Billmers |
National Starch And Chemical Investment Holding Copporation |
37 |
| #5 |
Robert Nering |
Johnson & Johnson |
31 |
| #6 |
Yeheng Zhu |
Bristol-Myers Squibb |
19 |
| #7 |
Gary J. Grover |
E.R. Squibb & Sons. |
18 |
| #8 |
Keith Freehauf |
Intervet |
14 |
| #9 |
Dennis G. Sekutowski |
Engelhard |
13 |
| #10 |
Scott Ciarrocca |
Johnson & Johnson |
12 |
| #11 |
John L. Robbins |
ExxonMobil |
11 |
| #12 |
Vulgens Schoen |
Johnson & Johnson |
8 |
| #12 |
Joseph Francis Choti |
Mlb Advanced Media |
8 |
| #12 |
Gary J. Pontecorvo |
— |
8 |
| #12 |
Peter J. Rohrbacher |
Congoleum |
8 |
| #16 |
Ivan Ladany |
Rca |
7 |
| #17 |
William M. Ball, Jr. |
Ingersoll-Rand |
6 |
| #17 |
Patrick L. Nosker |
Rutgers, The State University Of New Jersey |
6 |
| #19 |
James P. Rowell |
Chrome Red Technologies |
5 |
| #19 |
Mark R. Ziegenfuss |
Micrel |
5 |
| #19 |
Maureen Murphy |
Affymetrix |
5 |
| #19 |
Bernd R. Seizinger |
Bristol-Myers Squibb |
5 |
| #23 |
Anthony Coston |
C.R. Bard |
4 |
| #23 |
Carmen J. Gerrone |
Johnson & Johnson |
4 |
| #23 |
Cary N. Marzinsky |
ExxonMobil |
4 |
| #23 |
Edward Walker |
Johnson & Johnson |
4 |
| #23 |
Erik K. Jensen |
Health Hero Network |
4 |
| #28 |
Heather Klemmer |
Bank of America |
3 |
| #28 |
Sylvia McBrinn |
Pharmacia & Upjohn Company |
3 |
| #30 |
Linda L. Calkin |
— |
2 |
| #30 |
Robert E. Keay |
Fmc |
2 |
| #30 |
Alyssa Soto |
— |
2 |
| #30 |
Douglas Mark Knight |
Halliburton Energy Services |
2 |
| #30 |
James Rosikiewicz |
— |
2 |
| #30 |
James A. Housel |
AT&T |
2 |
| #30 |
Laurie A. Witucki |
American Cyanamid |
2 |
| #30 |
Charles Solt |
Lenox |
2 |
| #30 |
S. Lee Fineberg |
— |
2 |
| #30 |
Karen R. Zimm |
Ortho-Mcneil Pharmaceutical |
2 |
| #30 |
Edd Walker |
Johnson & Johnson |
2 |
| #30 |
Richard N. Devore |
Educational Testing Service |
2 |
| #42 |
Charles W. Cline |
National Starch And Chemical Investment Holding Copporation |
1 |
| #42 |
Joseph E. Dinchuk |
Bristol-Myers Squibb |
1 |
| #42 |
Edward D. Labow |
— |
1 |
| #42 |
John L. Fulwood |
— |
1 |
| #42 |
Sheila H. DeWitt |
Orchid Biosciences |
1 |
| #42 |
Katherine Salamone |
Saladax Biomedical |
1 |
| #42 |
Penny Luxich |
Johnson & Johnson |
1 |
| #42 |
James Vena |
— |
1 |
| #42 |
Bradley G. Mount |
— |
1 |